Abstract:Abstract Cyclin-dependent protein kinases (CDKs) regulate the eukaryotic cell cycle progression. Dysregulated cell cycle leading to unscheduled cell proliferation is a characteristic of many cancer subtypes. Since some tumor cells require specific interphase CDKs for proliferation, understanding CDKs activation mechanisms and their differential recognition of cognate cyclins and substrate proteins are essential for developing selective CDK inhibitors for cancer treatments. To date, while the crystal structure of the active CDK2 in complex with cyclin-E is available, no crystal structure for active CDK4 with its cognate cyclin-D is resolved. Here, we model the CDK4/cyclin-D complex as well as CDK2 in complex with cyclin-E to study the conformational dynamics and activation processes of G1 and G1/S phases CDKs, respectively. Extensive molecular dynamics (MD) simulations were performed for both CDK complexes with the kinases in different transition states to resolve the differences in their allosteric regulations at the atomic level. We illustrate that the inactive CDK4 in complex with cyclin-D is in the intermediate state on its pathway to activation in contrast to the fully active CDK2 in complex with cyclin-E, suggesting its activation mechanism is distinct from that of CDK2. This suggests that additional steps such as ATP binding, extension of the activation loop (A-loop), rotation of αC-helix towards “IN” conformation, phosphorylation of A-loop, and substrate binding are required for CDK4. CDK2 interacts with cyclin-E through a large interfacial area (or interface) that stabilizes the protein-protein interaction, while CDK4 has a smaller interfacial area (or interface) in the interaction with cyclin-D. Our simulations affirm experimental data on the current understanding of activation mechanisms of CDK2 and CDK4 and reveal additional atomistical characteristics of their dynamics and activations. Our works report the complete activation mechanisms of CDK2/4, providing insights into the inhibition of these complexes at an atomic level, and are useful for identifying potential targets for drug discovery in oncology. Citation Format: Wengang Zhang, Yonglan Liu, Mingzhen Zhang, Hyunbum Jang, Ruth Nussinov. Deciphering the activation mechanism of CDK4/cyclin-D complex that differs from the CDK2/cyclin-E complex [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 872.

Migratory Localization of Cyclin D2-Cdk4 Complex Suggests A Spatial Regulation of the G1-S Transition

Localization of Cyclin A at the Sites of Cellular DNA Replication.

The Cyclin D1 Proto-Oncogene is Sequestered in the Cytoplasm of Mammalian Cancer Cell Lines

Cell Cycle Progression Mechanisms: Slower Cyclin-D/cdk4 Activation and Faster Cyclin-E/cdk2.

Nuclear Localization of the Cell Cycle Regulator CDH1 and Its Regulation by Phosphorylation

Spatial regulation of greatwall by Cdk1 and PP2A-Tws in the cell cycle

Slower CDK4 and faster CDK2 activation in the cell cycle

Cyclin D- and E-Dependent Kinases and the P57(Kip2) Inhibitor: Cooperative Interactions in Vivo

Cyclin K regulates prereplicative complex assembly to promote mammalian cell proliferation

Cyclin B1 is Localized to Unattached Kinetochores and Contributes to Efficient Microtubule Attachment and Proper Chromosome Alignment During Mitosis.

Abstract P5-06-09: Cyclin d1 binding to chromatin and the induction of chromosomal instability requires the fuzzy domain

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

Exit from G1 and S Phase of the Cell Cycle is Regulated by Repressor Complexes Containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF

Nuclear Localization Of Cdk5 Is A Key Determinant In The Postmitotic State Of Neurons

Translational Repression of Cyclin D3 by a Stable G-quadruplex in Its 5′ UTR: Implications for Cell Cycle Regulation

CDK4 Protein is Degraded by Anaphase-Promoting Complex/cyclosome in Mitosis and Reaccumulates in Early G1 Phase to Initiate a New Cell Cycle in HeLa Cells.

Regulation of Cyclin E and Cancers

Abstract 872: Deciphering the Activation Mechanism of CDK4/cyclin-D Complex That Differs from the CDK2/cyclin-E Complex

Contribution of CDP/Cux, a transcription factor, to cell cycle progression.

The G1/S transition is promoted by Rb degradation via the E3 ligase UBR5

Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F